abstract |
Provided is a T cell immune response cDNA7 (TIRC7) costimulatory molecule capable of inhibiting the proliferation of peripheral blood molecular cells (PBMC). In particular, high affinity monoclonal and chimeric TIRC7 antibodies have been described. Compositions comprising such antibodies and their use for immune diseases are provided. |